High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$641K
$641,421
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Neervannan Seshadri
• COO
10b5-1 SellΔOwn -10.6%
2026-03-04
$641,421
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
10b5-1 SellΔOwn -10.6%
|
2026-03-04 | $641,421 | S | Form 4 |